AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Financial Post)
Byline: PAT ROQUE
Any company that creates medical products to treat obesity and skin blemishes sounds like a winner in the vain and pudgy North American market place.
Sure enough, Israel-based Syneron Medical Ltd. -- which makes laser devices that can zap unwanted fat, hair, wrinkles and acne -- has enjoyed a warm reception by investors since its debut on the Nasdaq stock exchange in August.
The shares began trading at US$12 each but soared to a high of US$37.84 last week, a stunning 215% increase in just four months and a clear sign that investors still love to pile onto a winning concept. The market capitalization…